VALLON PHARMACEUTICALS INC (VLON)
Institutional ownership reported to the SEC as of Q1 2023, across 9 quarters.
8
Reporting holders
$33.4K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | $8.2K | 22,708 | 0.00% | 2q | -38.0%-$5.0K |
| GEODE CAPITAL MANAGEMENT, LLC | $7.8K | 21,569 | 0.00% | 8q | HELD |
| STATE STREET CORP | $6.8K | 18,921 | 0.00% | 3q | HELD |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.5K | 15,109 | 0.00% | new | NEW |
| CITADEL ADVISORS LLC | $4.0K | 11,095 | 0.00% | new | NEW |
| UBS Group AG | $1.1K | 2,919 | 0.00% | 2q | -85.7%-$6.3K |
| Archer Investment Corp | $36 | 100 | 0.00% | 2q | HELD |
| WELLS FARGO & COMPANY/MN | $21 | 58 | 0.00% | 2q | +1.8% |
| Tower Research Capital LLC (TRC) | $4 | 11,907 | 0.00% | 6q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 8 | $33.4K | 92,479 | 2 | 1 | 2 | 0.0% |
| Q4 2022 | 8 | $43.5K | 150,666 | 7 | 0 | 0 | 0.0% |
| Q3 2022 | 7 | $74.0K | 263,540 | 3 | 1 | 1 | 0.0% |
| Q2 2022 | 8 | $141.0K | 221,901 | 3 | 1 | 2 | 0.0% |
| Q1 2022 | 12 | $765.0K | 406,836 | 3 | 4 | 3 | 0.0% |
| Q4 2021 | 12 | $2.9M | 478,961 | 3 | 2 | 3 | 0.0% |
| Q3 2021 | 11 | $2.8M | 378,493 | 3 | 5 | 3 | 0.0% |
| Q2 2021 | 9 | $3.1M | 579,259 | 3 | 2 | 1 | 0.0% |
| Q1 2021 | 9 | $2.4M | 526,486 | 9 | 0 | 0 | 0.0% |